MedPath

Is resistance training beneficial for female adults with Type 2 diabetes?

Not Applicable
Conditions
The health condition studied was Type 2 Diabetes, more specifically blood glucose control, lower limb strength and proprioception in the lower limbs.
Metabolic and Endocrine - Diabetes
Registration Number
ACTRN12609000131257
Lead Sponsor
Holly Evans
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
Female
Target Recruitment
40
Inclusion Criteria

Participants must be female aged between 60-80 years who have been diagnosed with Type 2 diabetes for greater than 6 months.
Blood glucose levels must be currently controlled by a combination of diet, exercise and/or oral hypoglycemic agents and all participants must have access to a mobile phone to receive and send SMS text messages. Participants will also be required to gain medical clearance from a General Practioner and undertake a HbA1c (Glycosylated hemoglobin) test before and after the program.

Exclusion Criteria

Participants will be excluded from participation in the study if they have participated in a supervised resistance training program (2 or more sessions per week) in the past 6 months, or if their diabetes is being managed with insulin. Individuals with recurrent hypoglycemic episodes, orthopedic, cardiovascular or respiratory conditions that would prevent participation in a progressive resistance training program will also be excluded from the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Knee flexion/extension isokinetic peak torque using KinCom Dynamometer[Taken at baseline, 12 and 16 weeks on all participants];Propriception in the lower limb - Sensation using a Semmes-Weinstein monofilaments on the plantar and dorsal surface of the foot[Taken at baseline, 12 and 16 weeks on all participants];Propriception in the lower limb - Vibration Perception Threshold using a Biothesiometer on plantar surface of the foot[Taken at baseline, 12 and 16 weeks on all participants]
Secondary Outcome Measures
NameTimeMethod
ower limb Isotonic Strength using One-repetition maximum technique[Taken at baseline, 4, 8, 12 and 16 weeks on all participants];Long term blood glycaemic control will be measured using Glycosylated hemoglobin (HbA1c). Blood will be taken by participants general practioner and labratory results will be fowarded to the researchers.[Taken at baseline, 12 and 16 weeks on all participants]
© Copyright 2025. All Rights Reserved by MedPath